Dr Rasha Al-Lamee is an Clinical Academic Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet and 3 secondary publications in Circulation and European Heart Journal. At Imperial College is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al-Lamee has over 100 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She is actively involved in the development and recruitment for many multi-centre international clinical trials.
She studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the North West London Cardiology rotation in 2013 and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee has over 16 years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
She is a deputy editor at EuroIntervention and an associate editor at the European Heart Journal. She is the NIHR CRN North West London Cardiovascular speciality lead and co-head of the cardiovascular theme of the Imperial Biomedical Research Centre. She is Phase 1c lead for clinical medicine at Imperial College London.
et al., 2018, Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease., Circulation, Vol:138, Pages:1780-1792
et al., 2018, Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial, The Lancet, Vol:391, ISSN:0140-6736, Pages:31-40